153 related articles for article (PubMed ID: 8126918)
1. Clinical and flow cytometric analyses of renal cell carcinomas with reference to incidental or non-incidental detection.
Sasaki Y; Homma Y; Hosaka Y; Tajima A; Aso Y
Jpn J Clin Oncol; 1994 Feb; 24(1):32-6. PubMed ID: 8126918
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
3. [Histopathological prognostic factors in 146 patients with renal cell carcinoma: comparison between incidental and non-incidental cases].
Uwatoko N; Suzuki S; Hayakawa M; Kimura F; Aoyagi T; Kyan A; Asano T; Odajima K; Nakajima F; Nakamura H
Hinyokika Kiyo; 1996 May; 42(5):341-5. PubMed ID: 8752535
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
Tamaki M; Maeda S; Deguchi T; Kawada Y
Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis.
Yu DS; Hsu CM; Lee WH; Chang SY; Ma CP
J Surg Res; 1993 Nov; 55(5):480-5. PubMed ID: 8231166
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Yokogi H
Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
[TBL] [Abstract][Full Text] [Related]
7. Prognostic parameters of renal cell carcinoma. Clinicopathologic and DNA image cytometric analysis in 133 pT3a cases.
Steinbach F; Stöckle M; Kiewel R; Störkel S; Stein R; Hohenfellner R
Eur Urol; 1993; 24(2):279-85. PubMed ID: 8375451
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma: incidental detection and pathological staging.
Siow WY; Yip SK; Ng LG; Tan PH; Cheng WS; Foo KT
J R Coll Surg Edinb; 2000 Oct; 45(5):291-5. PubMed ID: 11077776
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study on incidental renal cell carcinoma].
Yamaguchi K; Tominaga T; Nishimura Y
Hinyokika Kiyo; 1995 Feb; 41(2):93-9. PubMed ID: 7702013
[TBL] [Abstract][Full Text] [Related]
12. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
Eskelinen M; Lipponen P; Nordling S
Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
[TBL] [Abstract][Full Text] [Related]
13. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.
Schafhauser W; Liedl T; Elsässer D; Zörcher T; Schrott KM
Anticancer Res; 1999; 19(2C):1471-5. PubMed ID: 10365126
[TBL] [Abstract][Full Text] [Related]
15. Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S38-47. PubMed ID: 1575219
[TBL] [Abstract][Full Text] [Related]
16. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
17. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
18. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
al-Abadi H; Nagel R
Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
[TBL] [Abstract][Full Text] [Related]
19. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
20. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients.
Gudbjartsson T; Thoroddsen A; Petursdottir V; Hardarson S; Magnusson J; Einarsson GV
Urology; 2005 Dec; 66(6):1186-91. PubMed ID: 16360438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
